VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 110 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.85 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,506 | -83.3% | 10,904 | -75.4% | 0.00% | -84.6% |
| Q2 2023 | $506,685 | +30.9% | 44,252 | +44.1% | 0.01% | -51.9% |
| Q2 2020 | $387,000 | -37.1% | 30,703 | -54.3% | 0.03% | -40.0% |
| Q1 2020 | $615,000 | +106.4% | 67,176 | +214.5% | 0.04% | +150.0% |
| Q4 2019 | $298,000 | +20.2% | 21,358 | +48.1% | 0.02% | -14.3% |
| Q3 2019 | $248,000 | +22.8% | 14,421 | -32.9% | 0.02% | +61.5% |
| Q4 2018 | $202,000 | -38.4% | 21,504 | +23.3% | 0.01% | -43.5% |
| Q1 2018 | $328,000 | +84.3% | 17,437 | +62.2% | 0.02% | +15.0% |
| Q4 2017 | $178,000 | – | 10,750 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |